In the absence of these pieces of vital information it is perhaps unwise to draw any definite conclusions on the role of beta blocking agents in the transient arthropathies in these patients.
No takes yet. Share an insight, caveat, or question.
Walt et al. (1984) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: